Hospital
Buena Vista Regional Medical Center
Buena Vista Regional Medical Center was paid $4.05M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoBUENA VISTA REGIONAL MEDICAL CENTER
STORM LAKE, IA 50588
STORM LAKE, IA 50588
33aNPI1134191653assigned 02/07/2006
33bProvider typeCritical Access Hospital
28Total paid$4.05M
24GClaims67,477
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#4 of 79
Median peer was paid$801K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,686 | $337K | |
| 2019 | 9,568 | $449K | |
| 2020 | 7,878 | $416K | |
| 2021 | 11,164 | $722K | |
| 2022 | 11,297 | $815K | |
| 2023 | 11,898 | $825K | |
| 2024incomplete | 7,986 | $485K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 6,705 | 6,095 | $823K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 20% | 2,218 | 2,097 | $796K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 5,701 | 5,349 | $540K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.1% | 2,093 | 1,897 | $370K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.6% | 15,781 | 14,800 | $348K |
| 80053 | Comprehensive metabolic panel | 4.7% | 5,700 | 5,155 | $189K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.5% | 6,233 | 5,676 | $182K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.8% | 2,179 | 1,735 | $112K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 345 | 288 | $82K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 4,939 | 4,239 | $78K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.9% | 437 | 416 | $75K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.6% | 897 | 856 | $65K |
37 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.6% | 3,017 | $63K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 2,151 | $57K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.0% | 1,212 | $41K |
| 81001 | <1% | 2,439 | $35K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 767 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 347 | $25K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 467 | $17K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 265 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 266 | $15K |
| 87486 | <1% | 437 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 437 | $11K |
| 87581 | <1% | 437 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 215 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 135 | $7K |
| 87400 | <1% | 212 | $5K | |
| 87088 | <1% | 229 | $5K | |
| 84484 | <1% | 116 | $4K | |
| 86140 | <1% | 140 | $4K | |
| 83605 | <1% | 250 | $4K | |
| 83690 | <1% | 138 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 46 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 59 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 57 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 40 | $2K |
| 85379 | <1% | 31 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $1K |
| 84145 | <1% | 86 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 33 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 13 | $730.22 |
| 81025 | <1% | 31 | $705.24 | |
| 82728 | <1% | 15 | $667.97 | |
| 87807 | <1% | 15 | $558.96 | |
| 83615 | <1% | 28 | $534.02 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $448.95 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $433.68 |
| 85027 | <1% | 12 | $287.60 | |
| 99307 | <1% | 53 | $265.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKETCHAM, KRISTA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Buena Vista Regional Medical Center | Storm Lake, IA | $596K |
| Buena Vista Regional Medical Center | Storm Lake, IA | $35K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.